A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I.


Journal

Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456

Informations de publication

Date de publication:
12 2021
Historique:
received: 24 08 2021
revised: 21 10 2021
accepted: 22 10 2021
pubmed: 21 11 2021
medline: 29 3 2022
entrez: 20 11 2021
Statut: ppublish

Résumé

Glutaric aciduria type I (GA-I, OMIM # 231670) is an autosomal recessive inborn error of metabolism caused by deficiency of the mitochondrial enzyme glutaryl-CoA dehydrogenase (GCDH). The principal clinical manifestation in GA-I patients is striatal injury most often triggered by catabolic stress. Early diagnosis by newborn screening programs improved survival and reduced striatal damage in GA-I patients. However, the clinical phenotype is still evolving in the aging patient population. Evaluation of long-term outcome in GA-I patients recently identified glomerular filtration rate (GFR) decline with increasing age. We recently created the first knock-in rat model for GA-I harboring the mutation p.R411W (c.1231 C>T), corresponding to the most frequent GCDH human mutation p.R402W. In this study, we evaluated the effect of an acute metabolic stress in form of high lysine diet (HLD) on young Gcdh

Identifiants

pubmed: 34799272
pii: S1096-7192(21)00808-8
doi: 10.1016/j.ymgme.2021.10.003
pii:
doi:

Substances chimiques

Glutarates 0
Glutaryl-CoA Dehydrogenase EC 1.3.8.6
glutaric acid H849F7N00B

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-300

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Mary Gonzalez Melo (M)

Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: mary.gonzalez-melo@chuv.ch.

Andrea Orlando Fontana (AO)

Department of Nuclear Medicine and Molecular Imaging, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland. Electronic address: andrea.fontana@chuv.ch.

David Viertl (D)

Department of Nuclear Medicine and Molecular Imaging, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland. Electronic address: david.viertl@chuv.ch.

Gilles Allenbach (G)

Department of Nuclear Medicine and Molecular Imaging, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland. Electronic address: gilles.allenbach@chuv.ch.

John O Prior (JO)

Department of Nuclear Medicine and Molecular Imaging, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland. Electronic address: john.prior@chuv.ch.

Samuel Rotman (S)

Service of Clinical Pathology, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: samuel.rotman@chuv.ch.

René Günther Feichtinger (RG)

Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria. Electronic address: r.feichtinger@salk.at.

Johannes Adalbert Mayr (JA)

Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria. Electronic address: h.mayr@salk.at.

Michele Costanzo (M)

Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; CEINGE - Biotecnologie, Avanzate s.c.ar.l., 80145 Naples, Italy. Electronic address: michele.costanzo@unina.it.

Marianna Caterino (M)

Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; CEINGE - Biotecnologie, Avanzate s.c.ar.l., 80145 Naples, Italy. Electronic address: marianna.caterino@unina.it.

Margherita Ruoppolo (M)

Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; CEINGE - Biotecnologie, Avanzate s.c.ar.l., 80145 Naples, Italy. Electronic address: margherita.ruoppolo@unina.it.

Olivier Braissant (O)

Service of Clinical Chemistry, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: olivier.braissant@chuv.ch.

Frederic Barbey (F)

Department of Immunology, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: frederic.barbey@chuv.ch.

Diana Ballhausen (D)

Pediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne, Switzerland. Electronic address: diana.ballhausen@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH